NO concern…it’s now about who jumps first. As an pharmabod ..retired ,this platform is 90% deemed oven ready. It’s now about who’s going to licence/ buy the co tech.
As day is day…almost certainly .when …the Affimer platform is highly desirable ( and unique) , there are 20+ major pharma with declared oncology strategies…’hear a word,hear a word in season’.